STOCK TITAN

Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Azenta, Inc. (Nasdaq: AZTA) will participate in the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2022, starting at 4:00 pm PT. The presentation will be available via live webcast on Azenta's investor relations website. A replay will be accessible after the event. Azenta is a global provider of life sciences solutions, focusing on cold-chain sample management and genomic services across drug development and clinical research. The company, previously known as Brooks Automation, changed its name and ticker on December 1.

Positive
  • None.
Negative
  • None.

CHELMSFORD, Mass., Aug. 5, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, CA, on Thursday, August 11, 2022, which includes a presentation beginning at 4:00 pm PT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).

Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:

Sara Silverman
Head of Investor Relations
978.262.2635
ir@azenta.com

Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com 

Azenta logo (PRNewsfoto/Azenta)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-ubs-genomics-2-0-and-medtech-innovations-summit-301601020.html

SOURCE Azenta, Inc.

FAQ

What event is Azenta participating in on August 11, 2022?

Azenta will participate in the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2022.

What time does Azenta's presentation start during the summit?

The presentation starts at 4:00 pm PT on August 11, 2022.

How can I access the live webcast of Azenta's presentation?

The live webcast can be accessed through Azenta's investor relations website.

What services does Azenta provide in the life sciences sector?

Azenta offers cold-chain sample management solutions and genomic services for drug development and clinical research.

When did Azenta change its name and ticker symbol?

Azenta changed its name and ticker symbol on December 1, 2021.

Azenta, Inc.

NASDAQ:AZTA

AZTA Rankings

AZTA Latest News

AZTA Stock Data

2.05B
48.92M
2.24%
109.56%
9.83%
Medical Instruments & Supplies
Special Industry Machinery, Nec
Link
United States of America
BURLINGTON